Intellia Therapeutics Inc (NTLA)

133.36 +1.83  +1.39% NASDAQ Oct 25, 16:00 133.36 0.00  0.00% After-Hours: 20:00 USD

Intellia Therapeutics Underperform Recommendations

View 4,000+ financial data types
Browse...

Historical Underperform Recommendations Data

View and export this data going back to 2016. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Oct. 22, 2021 Upgrade
Oct. 21, 2021 Upgrade
Oct. 20, 2021 Upgrade
Oct. 13, 2021 Upgrade
Oct. 12, 2021 Upgrade
Oct. 8, 2021 Upgrade
Oct. 6, 2021 Upgrade
Oct. 5, 2021 Upgrade
Oct. 4, 2021 Upgrade
Sept. 23, 2021 Upgrade
Sept. 18, 2021 Upgrade
Sept. 16, 2021 Upgrade
Sept. 13, 2021 Upgrade
Aug. 13, 2021 Upgrade
Aug. 9, 2021 Upgrade
Aug. 6, 2021 Upgrade
Aug. 5, 2021 Upgrade
July 16, 2021 Upgrade
July 15, 2021 Upgrade
July 13, 2021 Upgrade
July 12, 2021 Upgrade
July 2, 2021 Upgrade
June 29, 2021 Upgrade
June 28, 2021 Upgrade
June 27, 2021 Upgrade
   
June 26, 2021 Upgrade
June 25, 2021 Upgrade
June 24, 2021 Upgrade
June 23, 2021 Upgrade
June 22, 2021 Upgrade
June 11, 2021 Upgrade
June 8, 2021 Upgrade
June 4, 2021 Upgrade
May 27, 2021 Upgrade
May 24, 2021 Upgrade
May 21, 2021 Upgrade
May 20, 2021 Upgrade
May 13, 2021 Upgrade
May 12, 2021 Upgrade
May 7, 2021 Upgrade
May 6, 2021 Upgrade
May 3, 2021 Upgrade
April 23, 2021 Upgrade
April 20, 2021 Upgrade
April 9, 2021 Upgrade
March 30, 2021 Upgrade
March 29, 2021 Upgrade
March 26, 2021 Upgrade
March 19, 2021 Upgrade
March 11, 2021 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View Underperform Recommendations for NTLA

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

Advertisement

Underperform Recommendations Range, Past 5 Years

Minimum Upgrade Oct 31 2016
Maximum Upgrade Oct 31 2016
Average Upgrade

News

SESN, KDMN and RMED among pre market gainers
SA Breaking News 10/21 08:32 ET
11 Best Genomic Stocks to Buy Now
Yahoo 10/19 09:25 ET
Insider Sell: Intellia Therapeutics
MT Newswires 10/13 16:34 ET
Insider Sell: Intellia Therapeutics
MT Newswires 10/08 09:27 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.